학술논문
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Document Type
Article
Author
Source
In Clinical Therapeutics October 2019 41(10):2041-2056
Subject
Language
ISSN
0149-2918